Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$52.6 - $67.34 $11.4 Million - $14.6 Million
217,263 New
217,263 $11.9 Billion
Q4 2022

Feb 14, 2023

BUY
$59.56 - $76.6 $13.3 Million - $17.1 Million
222,601 New
222,601 $13.9 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $1.45 Million - $1.96 Million
25,030 Added 11.91%
235,276 $16.6 Million
Q2 2022

Aug 15, 2022

BUY
$39.5 - $64.42 $30,099 - $49,088
762 Added 0.36%
210,246 $11.9 Million
Q1 2022

May 11, 2022

BUY
$43.74 - $62.76 $89,142 - $127,904
2,038 Added 0.98%
209,484 $13.1 Million
Q4 2021

Feb 11, 2022

BUY
$50.01 - $73.35 $558,811 - $819,612
11,174 Added 5.69%
207,446 $11.6 Million
Q3 2021

Nov 12, 2021

BUY
$59.21 - $78.66 $2.92 Million - $3.87 Million
49,243 Added 33.49%
196,272 $12.8 Million
Q2 2021

Aug 11, 2021

BUY
$51.39 - $66.9 $2.02 Million - $2.63 Million
39,249 Added 36.42%
147,029 $9.32 Million
Q1 2021

May 13, 2021

SELL
$49.14 - $59.89 $245,356 - $299,030
-4,993 Reduced 4.43%
107,780 $6.45 Million
Q4 2020

Feb 09, 2021

SELL
$42.19 - $51.5 $739,295 - $902,434
-17,523 Reduced 13.45%
112,773 $5.63 Million
Q3 2020

Nov 12, 2020

BUY
$35.33 - $51.04 $666,253 - $962,512
18,858 Added 16.92%
130,296 $6.65 Million
Q2 2020

Aug 12, 2020

BUY
$22.91 - $39.83 $894,795 - $1.56 Million
39,057 Added 53.96%
111,438 $3.91 Million
Q1 2020

May 06, 2020

BUY
$16.44 - $37.73 $117,759 - $270,259
7,163 Added 10.98%
72,381 $1.84 Million
Q4 2019

Feb 14, 2020

SELL
$19.57 - $28.96 $196,130 - $290,237
-10,022 Reduced 13.32%
65,218 $1.81 Million
Q3 2019

Nov 07, 2019

SELL
$26.92 - $42.41 $19,624 - $30,916
-729 Reduced 0.96%
75,240 $2.03 Million
Q2 2019

Aug 12, 2019

BUY
$18.54 - $40.97 $932,432 - $2.06 Million
50,293 Added 195.88%
75,969 $3.11 Million
Q1 2019

May 14, 2019

BUY
$13.32 - $24.35 $342,004 - $625,210
25,676 New
25,676 $615,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.